Existing-Home Sales Rose 3.1% in January
February 22, 2024 10:00 ET
|
National Association of Realtors®
Washington, D.C., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Key Highlights Existing-home sales expanded 3.1% in January to a seasonally adjusted annual rate of 4.00 million. Sales declined 1.7% from...
Nearly Half of Sellers’ Agents Said Staging a Home Reduced Its Time on Market, NAR Report Finds
March 30, 2023 09:00 ET
|
National Association of Realtors®
Washington, D.C., March 30, 2023 (GLOBE NEWSWIRE) -- Key Highlights Almost half of sellers’ agents (48%) reported that home staging decreased a property’s time on the market.Twenty percent...
OKYO Pharma Today Announces Director Acquires Shares
March 30, 2023 02:01 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
OKYO Pharma Today Announces Director Acquires Shares
March 29, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
OKYO Pharma Announces PDMR Dealing
March 24, 2023 03:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 22, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 21, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
GetBartering.com Launches to Support and Accelerate MSME Growth
August 23, 2022 09:00 ET
|
GetBartering.com
HALIFAX, Nova Scotia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- GetBartering.com, a B2B multi-vendor platform designed to provide micro, small, and medium enterprises (MSMEs) with access to critical...
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
March 14, 2022 16:05 ET
|
Sema4
37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue...
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
March 08, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., March 08, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, has been named to Fast Company’s prestigious annual...